Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00520416 · ClinicalTrials.gov registry record
Prospective, Non-Randomized Evaluation of Carbon Dioxide Gas as a Contrast Agent in Comparison With Iodinated Contrast in Endovascular Aneurysm Repair
A clinical trial, sponsored by University of Southern California.
- Completed
- Registry status
NCT00520416 is a clinical trial that has completed, run by University of Southern California.
The verdict
NCT00520416 has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
Study Summary
Endovascular repair of infrarenal abdominal aortic aneurysms (AAA) requires a contrast agent to identify the vascular anatomy and placement of the stent graft. Iodine contrast has traditionally been used, but has the potential to harm the kidneys. Another contrast agent is carbon dioxide gas. It has been proven safe to use, but the quality of the images it creates needs to be compared to iodine contrast. Patients in this study undergo the endovascular AAA repair as they normally, with the iodine contrast. At the end of surgery carbon dioxide gas contrast is given as an extra step. The images will be later evaluated.
Interventions
- PROCEDURE Carbon dioxide angiogram
Trial Details
| Field | Value |
|---|---|
| Start Date | 2006-10 |
| Est. Completion | 2008-07-20 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00520416
The ClinicalTrials.gov registry entry for NCT00520416 describes a study currently listed as completed, categorized as an unspecified phase. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Carbon dioxide angiogram is the first listed.
NCT00520416 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00520416 about?
NCT00520416 is a clinical study titled "Prospective, Non-Randomized Evaluation of Carbon Dioxide Gas as a Contrast Agent in Comparison With Iodinated Contrast in Endovascular Aneurysm Repair". Endovascular repair of infrarenal abdominal aortic aneurysms (AAA) requires a contrast agent to identify the vascular anatomy and placement of the stent graft. Iodine contrast has traditionally been used, but has the potential to harm the kidneys. Another contrast agent is carbon dioxide gas. It has...
What is the current status of trial NCT00520416?
This trial is currently completed. The study started on 2006-10. Estimated completion is 2008-07-20.
What interventions are being tested in trial NCT00520416?
The interventions under investigation include: Carbon dioxide angiogram (PROCEDURE).
Who is sponsoring clinical trial NCT00520416?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.